A two-step approach for diagnosing C. difficile has been found to be both cost-effective and significantly more sensitive than other methods in use AbstractLewis, J. (2009) Exploring the accuracy and ...
A study published in mBio, the online open-access journal of the American Society for Microbiology, may help create a test to predict which hospital patients are at the highest risk of developing a ...
Artificial intelligence (AI)-based drug developer Recursion has dosed the first patient in its Phase II ALDER trial (NCT06536465) assessing its first new chemical entity to be developed through its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
